WHC is still in active development. Read this to understand our approach.
depiction of NTYJJOPFIAHURM-UHFFFAOYSA-N.svg
isomerdesign

Histamine

Check on isomerdesign

pubchem

Histamine

Check on pubchem

drugmap

Ergotidine

Check on drugmap

Data

InChI: InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)

Synonyms: (1H-imidazol-4-yl)ethylamine,HMS3885M14,beta-Aminoethylglyoxaline,Spectrum5_000796,4-(2-Aminoethyl)-1H-imidazole,NCGC00015513-09,HISTAMINE [MI],L000292,Tox21_110166,BP-11484,histamine,Tox21_110166_1,117932-92-0,peremin,Imidazole, 4-(2-aminoethyl)-, 2-[4-Imidazolyl]ethylamine,Eramin, Imidazole-4-ethylamine,KBio2_003893,Ethylamine, 2-imidazol-4-yl-,Istamina [Italian],CHEBI:18295,bmse000744,DivK1c_000308,HMS3743G03,Lopac0_000595,2-(1H-Imidazol-4-yl)ethylamine,.beta.-Aminoethylglyoxaline, H7125_SIGMA, F411C768-A159-4FC0-A195-291A08BB03AA,2-(1H-Imidazol-4-yl)-ethylamine,MLS000069447,beta-aminothethylglyoxaline, Histamine, Free Base, Histaminum (TN),s10979,Histaminum (TN),Histamine Base,3h-histamine, Histamine (DCF), 2-(1H-Imidazol-4-yl)ethanamine,2-(4-Imidazolyl)ethylamine,KBioSS_000457,HMS1792G19,NCGC00015513-25,AB00053481_20,1H-Imidazole-4-ethanamine,BDBM7966,2-(1H-imidazol-4-yl)ethan-1-amine,2-(1H-Imidazol-4-yl)ethanamine #,65592-96-3,AMY33457,Histamine, Free Base - CAS 51-45-6,BBL004932,1qft,SMR000059091,SDCCGMLS-0066601.P001,Istamina,056H928,DSSTox_GSID_23125,HMS3403G19,DSSTox_RID_76884, Free histamine,Imidazole-4-ethylamine,HISTAMINE FREE BASE CRYSTALLINE,SMP1_000151,NCGC00093371-05,2-(3H-Imidazol-4-yl)-ethylamine,Ergotidine,beta-Imidazolyl-4-ethylamine,beta-Aminoethylimidazole,HISTAMINE [HSDB],2-imidazol-5-ylethylamine,Histamine, base, >=97.0% (NT),1avn,NCGC00015513-02, Istamina,AKOS000274386, L-histamine, Beta-Aminoethylglyoxaline,HSDB 3338,SCHEMBL2279,NINDS_000308,KBio2_003025,KBioGR_001580,Bio2_000869,CCRIS 6535,HISTAMINE [MART.],Spectrum2_000665,2-Imidazol-4-ylethylamine,F10913,ZINC388081,NCGC00093371-04, 2-(1H-imidazol-4-yl)ethan-1-amine,HMS1990G19,NCGC00015513-01,Histamine (DCF),Free histamine,NCGC00015513-06,NCGC00093371-02,MFCD00128939,2-(1H-Imidazol-5-yl)ethylamine,NCGC00015513-11,KBio2_006461,NSC-33792,ALBB-005968,F411C768-A159-4FC0-A195-291A08BB03AA, Beta-aminothethylglyoxaline,STK346752,Spectrum4_000960,Ergamine,HISTAMINE [WHO-DD],A828600,CCG-204684,J-505349,Histamine [USAN], 4-Imidazoleethylamine,L-histamine,WLN: T5M CNJ D2Z, Ergamine,2-(1H-imidazol-5-yl)ethanamine,IDI1_002144,NCGC00015513-08,Histamine, 2-(4-Imidazolyl)ethylamine,HMS1362G19,IDI1_000308, [3H]histamine, Beta-Aminoethylimidazole,KBioSS_001325,NSC 33792,GTPL1247,CHEMBL90,5-Imidazoleethylamine,Spectrum3_000452,51-45-6,[2-(1H-imidazol-4-yl)ethyl]amine,AKOS009158347,CS-0368357, Beta-Imidazolyl-4-ethylamine,KBio3_001344,2-(3H-imidazol-4-yl)ethanamine, Histamine,Histamine, analytical standard,AM20100377,Histamine Dihydrochloride (Salt/Mix), 4-(2-Aminoethyl)-1H-imidazole,GTPL1204,KBio3_000853,imido-,Histamine, Free Base,Lopac-H-7250,KBio3_000854,NCGC00015513-03, ALBB-005968, Histamine Base, Istamina [Italian],L-Histamin base,HISTAMINE [VANDF], Histamine [USAN],KBio2_001325,Bio2_000389,2-imidazol-4-yl-Ethylamine,CS-4697,4-(2-Aminoethyl)imidazole,EINECS 200-100-6,NSC33792,Histamine, >=97.0%,NCGC00015513-10,D08040,Histamine, EuropePharmacopoeia (EP) Reference Standard, 5-Imidazoleethylamine,BSPBio_002124, 2-(1H-imidazol-5-yl)ethanamine,Bio1_001465,KBio2_000457,HY-B1204,KBio2_005593,Histamine, Vetec(TM) reagent grade, >=97%,b-Imidazolyl-4-ethylamine,UNII-820484N8I3,NCGC00015513-04,BSPBio_001117,1H-Imidazole-5-ethanamine,Racemic histamine,CAS-51-45-6,Q61233,Bio1_000976,BDBM50121205,2-(1H-Imidazol-4-yl)ethanamine,FS-5386,C00388,NCGC00093371-03,Bio1_000487,NCGC00015513-07,EN300-78991, Theramine,4-Imidazoleethylamine,SY041787,BB 0241907, 2-(3H-Imidazol-4-yl)-ethylamine,.beta.-Aminoethylimidazole,SPBio_000729, 2-Imidazol-4-ylethylamine,820484N8I3,2-(4-Imidazolyl)ethanamine,AC-13185,[3H]histamine,KBio1_000308,SBI-0050577.P004,DB05381,KBioGR_000457,SDCCGSBI-0050577.P005,2-(3H-imidazol-4-yl)ethylamine,MFCD00005210,s3968,DSSTox_CID_3125,DTXSID4023125,714I940,Spectrum_000845,F2173-0575, 1H-Imidazole-4-ethanamine, ZERO/004089, 1H-Imidazole-5-ethanamine,NCGC00015513-05,.beta.-Imidazolyl-4-ethylamine,FT-0627839,Theramine,Opera_ID_1772,[2-(1H-imidazol-5-yl)ethyl]amine dihydrochloride,BCBcMAP01_000250, Histaminum,AB00053481_21

Estimated data

Solubility: 0.283 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 58.3% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.